""It is the mission of Mountain View Clinical Research, Inc. to provide the highest quality of data, promoting the growth and development of pharmaceutical research, while simultaneously never compromising the care, confidentiality and compassion of our patient volunteers." ​ At Mountain View Clinical Research, Inc. we work with esteemed physicians within the community as well as multiple pharmaceutical companies. Our staff is small allowing us the ability to develop a personal relationship with individuals that are eager to seek the latest advances in drug development. Our combined experience allows us the opportunity to study a vast array of therapeutic areas."

During the past decade, Mountain View Clinical Research Inc. conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 15 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 12 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mountain View Clinical Research Inc." #1 sponsor was "Pfizer" with 6 trials, followed by "Biohaven Pharmaceuticals, Inc." with 3 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored, "Actelion" with 2 trials sponsored and "ACADIA Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mountain View Clinical Research Inc." #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Grifols Biologicals, LLC" with 1 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator, "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Mountain View Clinical Research Inc." are "Osteoarthritis" (5 trials), "Multiple Sclerosis" (3 trials), "Osteoarthritis, Hip" (3 trials), "Chronic Pain" (2 trials) and "Obsessive-Compulsive Disorder" (2 trials). Many other conditions were trialed in "Mountain View Clinical Research Inc." in a lesser frequency.

Most popular intervention types in "Mountain View Clinical Research Inc." are "Drug" (25 trials), "Biological" (5 trials), "Other" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Ponesimod" (2 trials), "placebo" (2 trials), "ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)" (1 trials) and "Active Provant Therapy System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mountain View Clinical Research Inc." are 29 trials for "All" genders.

Currently, there are NaN active trials in "Mountain View Clinical Research Inc.". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Mountain View Clinical Research Inc., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Mountain View Clinical Research Inc., 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".